Tag Archives: biopharm

New Funding and Approval Pathways Prove Popular

By Rita Peters, Editorial Director, BioPharm International. Compared to other manufacturing and technology industries, the bio/pharmaceutical industry has one of the longest product development timelines. The research, development, testing, and regulatory review process typically extends for more than a decade, often exhausting the financial resources and commitment of investors. For patients with unmet medical needs, the […]
Posted in Biotech, FDA, Guest Blog, Regulatory | Also tagged , , , , , | Leave a comment

New Non-Profit Alliance of Big Pharma Firms

By Amy Ritter. Ten biopharmaceutical companies announced the formation of a nonprofit organization called TransCelerate BioPharma, the mission of which is to accelerate the development of new medicines by identifying and solving common drug development challenges.
Posted in Biotech, Deals, Guest Blog | Also tagged , , , , , , , , , | Leave a comment

Pharma Strives to Meet the Value Challenge

Of the 399 senior executives in the life sciences industry surveyed by the Economist Intelligence Unit (EIU) recently, 64% of respondents said that demonstrating value is a key challenge facing their business. The major issue, most agree, is that  stakeholders have different perceptions of what value is.
Posted in Strategy | Also tagged , | Leave a comment

Alliance Management is Being Neglected, Says Study

Survey finds disconnect between perceived importance of alliance management function at  C-level and actual commitment to it. The Rhythm of Business has released the results of a recent study titled The Practice of Alliance Management in the Biopharmaceutical Industry that examines the state of alliance management in pharmaceutical companies. The study, co-sponsored by the Biopharma […]
Posted in Biotech, leadership, Strategy | Also tagged , | Leave a comment
  • Categories

  • Meta